Literature DB >> 6476979

Cardiac electrophysiological effects of cibenzoline by acute and chronic administration in the anesthetized dog.

A Sassine, C Massé, A Dufour, J L Hirsch, M Cazes, P Puech.   

Abstract

The electrophysiological effects of cibenzoline on the myocardium of the anesthetized dog were studied by the endocavitary catheter method. Plasma cibenzoline levels were measured throughout. The cibenzoline effects on the sinus rate were negligible. The corrected sinus recovery time was significantly prolonged only following chronic oral administration. Atrial refractory periods were significantly increased only at the fifth minute following acute intravenous administration and after chronic oral treatment. The intranodal conduction time (AH) and the refractory periods in atrio-ventricular node were slightly modified or not at all. On the other hand, intraventricular and His-Purkinje (HV) conduction times, ventricular refractory periods and QRS duration were strongly increased following acute or chronic administration. This would imply a principal effect on the rapid kinetics sodium entry current. Nevertheless, the very marked effect upon this current could, under the experimental conditions adopted, have masked a lesser action upon other membrane permeabilities, involved in other myocardial structures.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6476979

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  5 in total

1.  Ventricular and atrial electrophysiological effects of a IC antiarrhythmic drug, cibenzoline, in the innervated dog heart. Role of sodium and calcium channels.

Authors:  Q Timour; J F Aupetit; J Loufoua-Moundanga; L Bertrix; M Freysz; G Faucon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

2.  Succinylcholine does not worsen bupivacaine-induced cardiotoxicity in pentobarbital-anaesthetized dogs.

Authors:  J E de La Coussaye; B P Bassoul; B Albat; P A Peray; J P Gagnol; J J Eledjam; A Sassine
Journal:  Can J Anaesth       Date:  1992-02       Impact factor: 5.063

3.  Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.

Authors:  J F Aupetit; Q Timour; J P Larbre; J Loufoua-Moundanga; I Kioueh; M Lopez; G Faucon
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

Review 4.  Cibenzoline. A review of its pharmacological properties and therapeutic potential in arrhythmias.

Authors:  D W Harron; R N Brogden; D Faulds; A Fitton
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

5.  Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ.

Authors:  Q Timour; J F Aupetit; J Loufoua-Moundanga; I Gerentes-Chassagne; I Kioueh; G Faucon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.